Wealthcare Advisory Partners’s Biogen BIIB Stock Holding History

Wealthcare Advisory Partners’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.02M	Sell	4,728 -661	-12%	-$126K	0.02%	515
2026 Q1	$988K	Buy	5,389 +87	+2%	+$16K	0.02%	520
2025 Q4	$933K	Buy	+5,302	New	+$866K	0.02%	532
2023 Q2	–	Sell	-809	Closed	-$225K	–	722
2023 Q1	$225K	Buy	809 +8	+1%	+$2.21K	0.01%	660
2022 Q4	$222K	Buy	+801	New	+$226K	0.01%	625
2021 Q3	–	Sell	-584	Closed	-$202K	–	548
2021 Q2	$202K	Sell	584 -35	-6%	-$10.6K	0.01%	524
2021 Q1	$173K	Buy	+619	New	+$167K	0.01%	514
2020 Q2	–	Sell	-503	Closed	-$159K	–	417
2020 Q1	$159K	Hold	503	–	–	0.02%	301
2019 Q4	$149K	Hold	503	–	–	0.02%	334
2019 Q3	$117K	Hold	503	–	–	0.02%	349
2019 Q2	$118K	Sell	503 -80	-14%	-$18.5K	0.02%	349
2019 Q1	$138K	Hold	583	–	–	0.02%	288
2018 Q4	$175K	Hold	583	–	–	0.03%	223
2018 Q3	$206K	Hold	583	–	–	0.04%	214
2018 Q2	$169K	Buy	583 +80	+16%	+$22.5K	0.03%	240
2018 Q1	$138K	Buy	503 +295	+142%	+$91.6K	0.03%	235
2017 Q4	$66K	Buy	208 +5	+2%	+$1.6K	0.02%	330
2017 Q3	$64K	Buy	+203	New	+$60.1K	0.02%	276

Other funds holding BIIB

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

ADEF

Adams Diversified Equity Fund Baltimore, Maryland $3.27B AUM 45.57% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

GIA

Gateway Investment Advisers Cincinnati, Ohio $10.1B AUM 40.26% 1-Year Est. Return

NGM

North Growth Management Vancouver, British Columbia, Canada $780M AUM 102.77% 1-Year Est. Return

QCM

QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return

CIM

Contravisory Investment Management Norwell, Massachusetts $566M AUM 42.93% 1-Year Est. Return

Wealthcare Advisory Partners's BIIB Position: Q2 2026 in Review

Wealthcare Advisory Partners reduced its Biogen (BIIB) stake by 12% in Q2 2026, selling an estimated $126K and leaving 4,728 shares worth $1.02M. The position accounts for 0.02% of the portfolio, ranked #515.

Wealthcare Advisory Partners first reported a position in BIIB in Q3 2017 and has held it in 18 quarters since. 205 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Wealthcare Advisory Partners held 4,728 shares of Biogen worth $1.02M as of Q2 2026.
Wealthcare Advisory Partners sold 661 Biogen shares in Q2 2026, an estimated $126K.
Biogen made up 0.02% of Wealthcare Advisory Partners's portfolio in Q2 2026, its #515 holding.
Wealthcare Advisory Partners first reported a position in Biogen in Q3 2017 and has held it in 18 quarters since.
205 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Wealthcare Advisory Partners's 13F filing for Q2 2026, filed 9 Jul 2026.